ALGERNON
Live / Registered — Registered (as of 16 Dec 2025)
What this means for you
Registered since 16 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88505722
- Registration number
- 8064250
- Mark type
- Stylized text
- Filed
- 09 Jul 2019
- Published for opposition
- 03 Sept 2024
- Registered
- 16 Dec 2025
- Attorney of record
- Nicholas J. Gingo
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of kidney diseases, liver diseases, and inflammatory bowel diseases and pulmonary diseases namely coughs and lung cancer
Owner
- ALGERNON PHARMACEUTICALS INC., VANCOUVER, BC, CA
- ALGERNON PHARMACEUTICALS INC., VANCOUVER, BC, CA
- ALGERNON PHARMACEUTICALS INC., VANCOUVER, BC, CA
- Breathtec Biomedical Inc., Vancouver, BC, CA
Prosecution history
- 16 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 21 Nov 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 01 Oct 2025 — NOTICE OF ALLOWANCE CANCELLED
- 21 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Oct 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 26 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2025 — SOU EXTENSION 1 GRANTED
- 25 Apr 2025 — SOU EXTENSION 1 FILED
- 25 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION
- 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER